SGLT2 Inhibitors Invokana & Ketoacidosis

Link May Exist Between SGLT2 Inhibitors like Invokana & Ketoacidosis

FDA findings show that from March 2013 to June 2014, as many as 20 cases of users of SGLT2 Inhibitors like Farxiga and Invokana developed ketoacidosis. In all of these cases, the users required ER visits or hospitalization. Since that time, many additional cases have been reported as well. The FDA is urging those who have suffered side effects relating to SGLT2 inhibitors to come forward and alert them of your experiences.